Startups
Celmatix is a next-generation women’s health company transforming the way women and their physicians leverage genomics and data to make more informed, proactive reproductive health decisions.
Overview
Location
United States, New York
Employees
11-50
Phone
+1 212-227-5341
Total raised
$5.5M
Founded date
2009
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 19
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 14, 2023 | Celmatix and Global Collaborators Announce Findings from Largest Genetic Study to Date on Endometriosis | Results reveal genetic basis of disease and link to other chronic pain conditions such as migraine and back pain that have implications for novel drug interventions Celmatix, the leading women’s health biotech focused on ovarian biology, an... |
| Apr 12, 2022 | This Biotech Startup Wants to Delay Menopause by 15 Years | (Photo: Dingzeyu Li/Unsplash)Menopause is no joke. Between hot flashes, sleep problems, chills, seemingly nonsensical mood swings, and associated health risks, this period of a person’s life is inconvenient for some and miserable for others... |
| Jun 24, 2021 | 52 Women-Led Startups Driving The Future Of HealthTech And FemTech | The Hero Arm, developed by Open Bionics, cofounded by Samantha Payne, is the world’s first ... [+] clinically approved 3D-printed bionic arm, with multi-grip functionality and empowering aesthetics.Open Bionics |
| Mar 24, 2021 | Celmatix Names Dr. Adrienne Day to Strategic Advisory Board | NEW YORK--(BUSINESS WIRE)--Mar 24, 2021-- Celmatix Inc., the leading women’s health biotech focused uniquely on ovarian biology, today announced that Dr. Adrienne Day has joined the company’s advisory board. Dr. Day joins as the company eye... |
| Mar 17, 2021 | Celmatix Names Dr. Stephen Palmer to Scientific Advisory Board | NEW YORK--(BUSINESS WIRE)--Mar 17, 2021-- Celmatix Inc., the leading women’s health biotech focused uniquely on ovarian biology, today announced that Dr. Stephen Palmer has joined its Scientific Advisory Board. Along with other board member... |
| Dec 13, 2019 | A startup that promised to use genetics to help people conceive shut down its lab and laid off employees after it failed to raise funding. In a new lawsuit, it blames 23andMe. | Courtesy Celmatix Celmatix CEO Piraye Beim Advertisement Celmatix, a reproductive health startup, on Tuesday sued consumer genetics giant 23andMe for breach of contract. 23andMe partnered with Celmatix in 2016 on research into women's healt... |
| Aug 7, 2018 | Which New York City healthcare companies raised the most dough from investors in Q2? | Thrive Global, the consumer wellness platform headed up by Arianna Huffington, was at the top of the list. In May, it announced it brought in $43 million. Aetion, which focuses on real-world data through the science and analytics platform i... |
| May 28, 2018 | Startup che meritano attenzione, secondo i più importanti fondi di investimento | È stato chiesto ai più importanti fondi di venture capital di tutto il mondo (tra cui Accel, Andreessen Horowitz, Battery Ventures, Bessemer, Greylock Ventures, Kleiner Perkins e Sequoia) di segnalare le startup di cui potremmo sentir parla... |
| Aug 2, 2017 | Can a genetic test really boost your odds of becoming pregnant? | “Take charge of your biological clock,” the invitation urged. It beckoned women to an evening seminar in Manhattan. There, they received a coupon for the latest in fertility management: a genetic test marketed as a way to help maximize thei... |
Show more
Reviews 0
FAQ about Celmatix
When was Celmatix founded?
Celmatix was founded in 2009.
How much funding has Celmatix raised?
Celmatix has raised $5.5M in total across 1 funding round.
What has the press written about Celmatix?
Parsers VC has collected 19 articles mentioning Celmatix, among them “Celmatix and Global Collaborators Announce Findings from Largest Genetic Study to Date on Endometriosis” (Mar 14, 2023) and “This Biotech Startup Wants to Delay Menopause by 15 Years” (Apr 12, 2022).
Is Celmatix still active?
Yes, Celmatix is active; its latest activity on Parsers VC dates from Oct 22, 2024.